Taimoxin-F en es it fr

Taimoxin-F Brand names, Taimoxin-F Analogs

Taimoxin-F Brand Names Mixture

  • No information avaliable

Taimoxin-F Chemical_Formula


Taimoxin-F RX_link

No information avaliable

Taimoxin-F fda sheet

Taimoxin-F msds (material safety sheet)

Taimoxin-F Synthesis Reference

No information avaliable

Taimoxin-F Molecular Weight

167.205 g/mol

Taimoxin-F Melting Point

96 oC

Taimoxin-F H2O Solubility

2500 mg/L

Taimoxin-F State


Taimoxin-F LogP


Taimoxin-F Dosage Forms

No information avaliable

Taimoxin-F Indication

Used for the short-term treatment of insomnia, however, it generally has been replaced by other sedative-hypnotic agents.

Taimoxin-F Pharmacology

Ethinamate is used to treat insomnia (trouble in sleeping). However, it has generally been replaced by other medicines for the treatment of insomnia. If ethinamate is used regularly (for example, every day) to help produce sleep, it is usually not effective for more than 7 days. Structurally, it does not resemble the barbiturates, but it shares many effects with this class of drugs; the depressant effects of ethinamate are, however, generally milder than those of most barbiturates. Continued and inappropriate use of ethinamate can lead to tolerance and physical dependence, with withdrawal symptoms very similar to those of the barbiturates.

Taimoxin-F Absorption

Rapidly absorbed following oral administration.

Taimoxin-F side effects and Toxicity

Symptoms of overdose include shortness of breath or slow or troubled breathing, slow heartbeat, severe weakness, chronic confusion, slurred speech, and staggering.

Taimoxin-F Patient Information

Taimoxin-F Organisms Affected

Humans and other mammals